New-Onset Type 1 Diabetes in an Elderly Female on Pembrolizumab

Am J Med Sci. 2022 Apr;363(4):371-372. doi: 10.1016/j.amjms.2021.10.024. Epub 2022 Jan 5.

Authors

Saurabh Bansal¹, Daniel Saca¹, Daniel Getz¹, Asra Rab¹, Namrata Singhania²

Affiliations

¹ Department of Internal Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA.
² Department of Hospital Medicine, Mount Carmel East Hospital Columbus, Ohio, USA. Electronic address: namrat09@gmail.com.

PMID: 34995577
DOI: 10.1016/j.amjms.2021.10.024

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / adverse effects
Carcinoma, Non-Small-Cell Lung*
Diabetes Mellitus, Type 1* / drug therapy
Female
Humans
Lung Neoplasms*

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab